Andrea Alimonti
Affiliations: | Department of Health Sciences and Technology | Eidgenössische Technische Hochschule Zürich, Zürich, ZH, Switzerland |
Google:
"Andrea Alimonti"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Colucci M, Zumerle S, Bressan S, et al. (2024) Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell |
| Alimonti A. (2023) Overcoming immune evasion in advanced prostate cancer. Clinical Advances in Hematology & Oncology : H&O. 21: 533-535 |
| Guo C, Sharp A, Gurel B, et al. (2023) Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. Nature |
| Guccini I, Tang G, To TT, et al. (2023) Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer development. Iscience. 26: 107368 |
| Pernigoni N, Guo C, Gallagher L, et al. (2023) The potential role of the microbiota in prostate cancer pathogenesis and treatment. Nature Reviews. Urology |
| Troiani M, Colucci M, D'Ambrosio M, et al. (2023) Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer. Nature Communications. 14: 4386 |
| Brina D, Ponzoni A, Troiani M, et al. (2023) The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nature Cancer |
| Alvarez-Arzola R, Bancaro N, Lai P, et al. (2023) VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer. Cell Communication and Signaling : Ccs. 21: 76 |
| Guo C, Figueiredo I, Gurel B, et al. (2023) Erratum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [Eur Urol 2023;83(3):224-38]. European Urology |
| Bancaro N, Calì B, Troiani M, et al. (2023) Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer. Cancer Cell. 41: 602-619.e11 |